Greenleaf Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.25M | Buy |
|
|||||
|
2025
Q2 | $890K | Sell |
|
|||||
|
2025
Q1 | $743K | Buy |
|
|||||
|
2024
Q4 | $641K | Buy |
|
|||||
|
2024
Q3 | $748K | Sell |
|
|||||
|
2024
Q2 | $661K | Sell |
|
|||||
|
2024
Q1 | $428K | Sell |
|
|||||
|
2023
Q4 | $562K | Buy |
|
|||||
|
2023
Q3 | $449K | Sell |
|
|||||
|
2023
Q2 | $498K | Sell |
|
|||||
|
2023
Q1 | $553K | Buy |
|
|||||
|
2022
Q4 | $641K | Buy |
|
|||||
|
2022
Q3 | $535K | Buy |
|
|||||
|
2022
Q2 | $373K | Buy |
|
|||||
|
2022
Q1 | $388K | Sell |
|
|||||
|
2021
Q4 | $540K | Hold |
|
|||||
|
2021
Q3 | $602K | Hold |
|
|||||
|
2021
Q2 | $540K | Buy |
|
|||||
|
2021
Q1 | $444K | Buy |
|
|||||
|
2020
Q4 | $405K | Sell |
|
|||||
|
2020
Q3 | $456K | Buy |
|
|||||
|
2020
Q2 | $459K | Hold |
|
|||||
|
2020
Q1 | $337K | Hold |
|
|||||
|
2019
Q4 | $357K | Buy |
|